drugset / Trial / NCT01812525

Moderate to Severe Bronchiolitis: Standard Therapy Versus Therapy With NaCl 3% Inhalations

NCT01812525

RandomizedParallel-groupOpen-labelTreatment

Summary

Our study will investigate inhalation therapy of NaCl 3% compared to standard therapy with no inhalation in the treatment of moderate to severe bronchiolitis. The impact on length of hospital stay will be analyzed.

Timeline

Start
2013-03
Primary completion
2016-04
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator sodium chloride Unknown 4 ml Inhaled

Indications